Mn2+ dopant-controlled synthesis of NaYF4:Yb/Er upconversion nanoparticles for in vivo imaging and drug delivery

Mn2+ dopant-controlled synthesis of NaYF4:Yb/Er upconversion nanoparticles for in vivo imaging and drug delivery

Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Détails bibliographiques
Publié dans:Advanced materials (Deerfield Beach, Fla.). - 1998. - 24(2012), 9 vom: 02. März, Seite 1226-31
Auteur principal: Tian, Gan (Auteur)
Autres auteurs: Gu, Zhanjun, Zhou, Liangjun, Yin, Wenyan, Liu, Xiaoxiao, Yan, Liang, Jin, Shan, Ren, Wenlu, Xing, Gengmei, Li, Shoujian, Zhao, Yuliang
Format: Article en ligne
Langue:English
Publié: 2012
Accès à la collection:Advanced materials (Deerfield Beach, Fla.)
Sujets:Journal Article Research Support, Non-U.S. Gov't Antibiotics, Antineoplastic Drug Carriers sodium yttriumtetrafluoride Manganese 42Z2K6ZL8P Yttrium 58784XQC3Y Erbium plus... 77B218D3YE Doxorubicin 80168379AG Ytterbium MNQ4O4WSI1 Fluorides Q80VPU408O
Description
Résumé:Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Pure dark red emission (650-670 nm) of NaYF(4):Yb/Er upconversion nanoparticles (UCNPs) is achieved by manganese ions (Mn(2+)) doping. In addition, the Mn(2+)-doping can also control the crystalline phase and size of the resulting UCNPs simultaneously. Drug delivery studies suggest the promise of these UCNPs as drug carriers for intracellular drug delivery and eventually as a multifunctional nanoplatform for simultaneous diagnosis and therapy
Description:Date Completed 12.06.2012
Date Revised 30.09.2020
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.201104741